Cargando…
Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin
Autor principal: | Rhee, Sang Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695718/ https://www.ncbi.nlm.nih.gov/pubmed/38043781 http://dx.doi.org/10.4093/dmj.2023.0351 |
Ejemplares similares
-
Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats
por: Pang, Minyeong, et al.
Publicado: (2022) -
Spatiotemporal analyses of the epidemiological characteristics of diabetes mellitus
por: Rhee, Sang Youl
Publicado: (2021) -
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
por: Kim, Min-Soo, et al.
Publicado: (2023) -
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
por: Han, Kyung Ah, et al.
Publicado: (2023) -
Navigating the new normal in ophthalmology
por: Honavar, Santosh G
Publicado: (2020)